CI

At a glance

ClinicalIndex Comparison Record
Phase 2Completed· 66 enrolled
Drug / intervention
peripherally inserted central catheter (PICC)device
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT03299868
NCT03299868Phase 2Completed
CompareCT.gov

Comparison of Safety, Efficacy, and Patient-perceived Satisfaction Between Initial Routine Peripherally Inserted Central Catheters Insertion and General Intravenous Access in Terminally Ill Cancer Patients: A Randomized Phase II Study

Pusan National University Yangsan Hospital·interventional·Posted Oct 3, 2017·Updated Aug 25, 2020

In Brief

A Phase 2 clinical trial evaluating peripherally inserted central catheter (PICC) for Peripherally Inserted Central Catheter and Intravenous Access. Completed, enrolled 66 participants across 1 site.

Detailed Summary

To establish the IV access strategy for terminally ill cancer patients, using comparisons of the safety, efficacy, and patient-perceived satisfaction between the initially routine PICC insertion group (routine PICC group) and general IV access group (optional PICC group).

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsPeripherally Inserted Central Catheter, Intravenous Access
CountriesSouth Korea
Collaborators--

Timeline

Phase 2CompletedFinished
201820192020202120222023202420252026
First PostedOct 3, 2017
Enrollment StartMay 1, 2017
Primary CompletionJun 30, 2020
TodayJul 2, 2026
Enrollment to primary: 3.2 yearsPosted 8.7 years ago

Interventions

peripherally inserted central catheter (PICC)device

comparisons of the safety, efficacy, and patient-perceived satisfaction between the initially routine PICC insertion group (routine PICC group) and general IV access group (general IV group)